Paperonium

Rheumatology · Ann Rheum Dis · 2021

Summary: 0.10% of patients with inflammatory joint disease died of Covid. Its own counts: 0.146%.

The summary0.10%Its own counts: 161 of 110,5670.146%0%0.05%0.1%0.15%
The summary0.10%Its own counts: 161 of 110,5670.146%0%0.05%0.1%0.15%

Share of the patients who died of Covid, March to September 2020

The paper says

A study followed 110,567 patients with rheumatoid arthritis or a related inflammatory joint disease from 1 March to 1 September 2020. Its summary says 0.10% of them died of Covid. Its results section, its results table and its discussion all repeat 0.10%.

Its own data show

The results table prints the count beside the share: “161 (0.10%)”. 161 deaths among 110,567 patients is 0.146%, which rounds to 0.15%. The 161 holds up: it is the table’s deaths among rheumatoid arthritis patients (134) plus those among the rest (27). Rounding cannot give 0.10%: that would take 106 to 116 deaths.

A death risk here is just deaths divided by patients: the paper’s methods define it that way, and nearly every other risk in the same table follows that rule. It matters because the paper offers this figure for counselling patients, as about 1 in 1,000. Its own counts give about 1.5 in 1,000.

“The summary” means the paper’s abstract: the short summary printed at its top, which is the part most readers see.

Read the paper →Full technical write-up →

Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study · Ann Rheum Dis (2021) · doi:10.1136/annrheumdis-2021-219845